(The Fiscal Times)
Drug price-comparison platform GoodRx recently released an expanded rundown of the 20 most costly drugs in the U.S., based on the list price set by manufacturers — which can be very different from the price insurers or patients pay.
“Turns out, more drugs are coming out with sky-high prices,” GoodRx researcher Tori Marsh wrote. “Since May, three newly approved drugs have made their way into our most expensive list, and all 20 have a list price of more than $25,000 for a monthly supply. Some of these medications are for rare genetic disorders that afflict few people, while others treat more common conditions like pulmonary hypertension and hepatitis C.” Read more